Merck’s HPV Vaccine Gardasil Shown Safe in Kaiser Study

Merck & Co.’s Gardasil, the human papillomavirus vaccine to prevent cervical cancer, was shown to be safe in the second large-scale study in the past year of side effects since the drug was approved six years ago.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.